Clinical outcomes according to dose reduction criteria of apixaban in Japanese elderly patients with atrial fibrillation: J-ELD AF Registry subanalysis
-
Published:2021-01-24
Issue:7
Volume:36
Page:1035-1046
-
ISSN:0910-8327
-
Container-title:Heart and Vessels
-
language:en
-
Short-container-title:Heart Vessels
Author:
Akao MasaharuORCID, Yamashita Takeshi, Suzuki Shinya, Okumura Ken, Sakuma Ichiro, Ajioka Masayoshi, Kusano Kengo, Ohki Takahiro, Kimura Takeshi, Akao Masaharu, Asakawa Tetsuya, Okabe Masaaki, Ogimoto Akiyoshi, Ikeda Takanori, Nishida Taku, Mizukami Akira, Tabuchi Toshifumi, Yamashita Takeshi, Suzuki Yasushi, Ako Junya, Takatsuki Seiji, Sumimoto Takumi, Hagiwara Nobuhiwa, Yamada Takahisa, Fukatani Masahiko, Ito Nobuhiko, Nakajima Kohsuke, Michishige Hiroyuki, Koretsune Yukihiro, Kamiyama Kenji, Sugi Naoki, Kubo Takaaki, Yagi Tetsuo, Sugiura Atsushi, Momiyama Yukihiko, Iwao Tetsu, Watanabe Tetsuya, Nakanishi Tohru, Takeishi Yasuchika, Kameda Kunihiko, Inoue Teruo, Funazaki Toshikazu, Doi Naofumi, Higuchi Yoshiharu, Tsuboko Yusuke, Sato Yoshihiro, Machii Kazuo, Hiyoshi Yasunaga, Harada Masahiko, Inoko Moriaki, Takenaka Hiroyuki, Furukawa Yutaka, Ando Kenji, Nakagawa Yoshihisa, Yoshitani Kazuyasu, Takahashi Mamoru, Miki Shinji, Murakami Tomoyuki, Inoue Koichi, Takano Yuzuru, Shimizu Wataru, Arakawa Tomoharu, Sata Masataka, Shimizu Shogo, Hagii Joji, Yoshimoto Tetsuyuki, Fujii Shinya, Takahashi Naohiko, Tsuji Hikari, Nakajima Tamio, Watanabe Masayuki, Watanabe Eiichi, Arikawa Masaya, Ota Akira, Ozaki Masaharu, Misumi Ikuo, Uematsu Masaaki, Hatayama Toru, Sato Atsushi, Narita Hidetoshi, Toyamori Hiroshi, Yoshida Kazuhiro, Furukawa Kayoko, Komatsu Takashi, Shimizu Akihiko, Onodera Tomoya, Igarashi Morio, Fujino Takao, Hasegawa Shinji, Suzuki Tomomi, Yuge Masaru, Inoue Takeshi, Kudo Takeshi, Koeda Toshihiko, Ohwada Takayuki, Sumi Hirokuni, Yamabe Jinko, Ozawa Mahito, Sugiura Toshiyuki, Okumura Ken, Tomita Hirofumi, Kondo Kazuhiko, Morikawa Yasuhide, Haruta Shoji, Ishida Shuji, Shirotani Manabu, Inoue Fumitaka, Sato Koji, Fujimoto Kazuteru, Katahira Yoshiaki, Mizukami Akira, Matsumura Norihiko, Tayama Shinji, Tsunoda Ryusuke, Ikeguchi Shigeru,
Funder
Bristol-Myers Squibb
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference19 articles.
1. Kannel WB, Wolf PA, Benjamin EJ, Levy D (1998) Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82:2N-9N 2. Wolf PA, Abbott RD, Kannel WB (1991) Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22:983–988 3. Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383:955–962 4. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981–992 5. Cirincione B, Kowalski K, Nielsen J, Roy A, Thanneer N, Byon W, Boyd R, Wang X, Leil T, LaCreta F, Ueno T, Oishi M, Frost C (2018) Population pharmacokinetics of apixaban in subjects with nonvalvular atrial fibrillation. CPT Pharmacomet Syst Pharmacol 7:728–738
|
|